African and Asian doctors have been brought to the UK from “red list” countries, from which “active recruitment” is banned, and forced to work illegal hours, according to reports.
Both for-profit and public healthcare operators in Poland have been struggling to cope after a large influx of Ukrainian refugees. HBI speaks to contacts in Poland to find out more.
Hôpital du Jura Bernois, a subsidiary of Switzerland's second largest hospital group Swiss Medical Network, is to become the country's first integrated payor-provider, after health insurer Visana bought a 32.4% stake. From January 1 2023 it will offer insurance alongside its hospital and outpatient services to inhabitants of the Jura Arc region.
American investment management firm Elliott has taken a minority stake in Fresenius Helios, the largest hospital group in Europe by revenue. The move prompts fresh questions about Fresenius' new CEO's intentions for the company.
The slump in healthcare listed stocks and downward valuations of private businesses are encouraging potential buyers to examine enticing European healthcare enterprises.
Saudi Arabia’s health ministry is making $13bn (SR48bn) plans for 100 healthcare projects that will involve the private sector. The public-private partnership proposals include constructing two new medical cities, a project to provide 900 beds for medical rehabilitation, and long-term care services, and it looks like foreign investors are actively being courted.
Transform Hospital Group, a financially troubled UK-based medical aesthetics, cosmetic and weight loss surgery-focussed business, has been forced to lay off staff to secure its future.
The company formed as a result of the merger between Euromedica and Imithea, the parent company of Henry Dunant, Greece’s largest private hospital, is unlikely to sell for three years, HBI hears. Click here to read our reports on the for-profit hospital sector, and here to read more about Euromedica, and here to read more […]
Rumours circulate that Quironsalud, the Spanish hospital subsidiary of hospital chain Fresenius Helios, may be sold to private equity firm CVC or KKR, HBI hears. But others say the new CEO of Helios' parent, Fresenius SE, is unlikely to go for the strategy and suggest the dialysis arm could be put on the block instead.
Healthcare Business International users cookies to improve the functionality, performance, and effectiveness of our communications. Detailed information on the use of cookies is provided in our Cookies Policy. By continuing to use this site, or by clicking "I agree" you consent to the use of cookies.
